针对新诊断炎症性关节炎的自管理干预效果:随机对照试验研究方案
这项实用性多中心随机对照试验将在三家丹麦医院连续纳入130名新诊断类风湿关节炎、银屑病关节炎或中轴型脊柱关节炎成人,1:1随机接受NISMA自管理干预联合常规照护或单纯常规照护,主要结局为12个月时heiQ技能获取领域评分,随访至24个月。
要点
- NISMA包含三次必选护士主导个体会话和两次可选多学科团体会话,历时12个月。
- 主要结局为12个月时heiQ「技能与技术获取」领域评分,采用意向性分析。
- 若试验成功,NISMA或可显著增强非药物管理,兼顾新诊断IA患者的身心需求。
核心结论
- 该随机对照试验将为靶向自管理干预对新诊断炎症性关节炎患者的疗效提供重要见解。
- 若成功,NISMA干预或可显著增强非药物管理,为照护新诊断IA患者的身心需求提供综合方法。
研究设计与样本
- 实用性、多中心随机对照试验,从三家丹麦医院连续纳入130名新诊断类风湿关节炎、银屑病关节炎或中轴型脊柱关节炎成人。
- 按1:1随机分配至NISMA联合常规照护组或单纯常规照护组,评估在基线、12个月(主要)和24个月(延伸)进行。
关键数值与推荐
- 主要结局为健康教育与影响问卷(heiQ)「技能与技术获取」领域评分。
- 主要分析采用协方差分析(ANCOVA),校正基线、中心和诊断,估计组间差异及双侧95%CI。
- 关键次要终点按预先设定的分层(gatekeeping)顺序评估,事后分析均为探索性。
临床怎么用
- 对照组接受常规照护,包括与风湿科医生的计划会诊和护士服务。
- NISMA包括三次必选护士主导个体会话和两次可选多学科团体会话,在12个月内实施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients newly diagnosed with inflammatory arthritis (IA) often face substantial physical, psychological, and social challenges despite advances in pharmacological management. OBJECTIVE: To investigate the efficacy of the "Newly diagnosed with Inflammatory arthritis-a Self-MAnagement intervention" (NISMA) and usual care, compared to usual care alone (control group), in adults with newly diagnosed IA. METHODS: This pragmatic, multicenter randomized controlled trial (RCT) will enroll 130 adults with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or axial spondyloarthritis (axSpA) recruited consecutively from three Danish hospitals and randomized 1:1 to NISMA plus usual care or usual care alone. The control group receives usual care, which consists of planned consultations with a rheumatologist and access to nurses. NISMA comprises three mandatory individual nurse-led sessions with two optional multidisciplinary group sessions delivered over 12 months. Assessments occur at baseline, 12 months (primary), and 24 months (extension). The primary outcome is the Health Education Impact Questionnaire (heiQ) "skill and technique acquisition" domain. STATISTICAL ANALYSIS: Analyses follow the intention-to-treat principle. For the primary analysis, analysis of covariance (ANCOVA) adjusted for baseline, center, and diagnosis will estimate between-group differences with two-sided 95% CIs. Model assumptions (normality, homoscedasticity) will be checked (Q-Q plots, residual diagnostics). If violated, pre-specified alternatives (e.g., transformation, rank-based ANCOVA, or nonparametric tests) will be used. Missing data will be addressed using multiple imputation. Key secondary endpoints will be assessed in a pre-specified hierarchical (gatekeeping) order; any post hoc analyses will be exploratory. Extension analyses at 24 months will use linear mixed-effects models. DISCUSSION: This randomized controlled trial will provide essential insights about the efficacy of a targeted self-management intervention for newly diagnosed patients with inflammatory arthritis. If successful, the NISMA intervention could significantly enhance non-pharmacological management, providing a comprehensive approach to addressing both physical and psychological needs in caring for patients newly diagnosed with IA. TRIAL REGISTRATION {2B}: ClinicalTrials.gov, nr.: NCT06533423. Registered on December 19, 2024. PROTOCOL VERSION {3}: 22.09.2025. Version 2.
引用
- Lindgren LH, Thomsen T, Hetland ML, et al. Effect of a self-management intervention for newly diagnosed inflammatory arthritis: study protocol for a randomized controlled trial. Trials. 2025. PMID: 41310759. doi:10.1186/s13063-025-09192-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。